Picture of LENSAR logo

LNSR LENSAR Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for LENSAR, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-19.8-19.6-19.9-14.4-31.4
Depreciation
Amortisation
Non-Cash Items9.617.917.238.9928.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital-6.19-0.042-5.58-7.78-3.04
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-13.8-8.97-14.9-9.66-2.27
Capital Expenditures-0.366-0.354-0.115-0.236-0.156
Purchase of Fixed Assets
Other Investing Cash Flow Items0.040-3.92-2
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.326-0.354-0.115-4.16-2.16
Financing Cash Flow Items-2.4-0.052-0.286
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities500.361-1.9919.80.078
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash35.9-8.96-175.95-4.36